Tuberc Respir Dis.  2019 Oct;82(4):269-276. 10.4046/trd.2018.0090.

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 1. Introduction

Affiliations
  • 1Division of Respiratory and Allergy, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
  • 2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea.
  • 3Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • 4Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea.
  • 5Division of Allergy and Pulmonology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
  • 6Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. mpchung@skku.edu

Abstract

Idiopathic interstitial pneumonia (IIP) is a histologically identifiable pulmonary disease without a known cause that usually infiltrates the lung interstitium. IIP is largely classified into idiopathic pulmonary fibrosis, idiopathic non-specific interstitial pneumonia, respiratory bronchiolitis-interstitial lung disease (ILD), cryptogenic organizing pneumonia, desquamative interstitial pneumonia, and acute interstitial pneumonia. Each of these diseases has a different prognosis and requires specific treatment, and a multidisciplinary approach that combines chest high-resolution computed tomography (HRCT), histological findings, and clinical findings is necessary for their diagnosis. Diagnosis of IIP is made based on clinical presentation, chest HRCT findings, results of pulmonary function tests, and histological findings. For histological diagnosis, video-assisted thoracoscopic biopsy and transbronchial lung biopsy are used. In order to identify ILD associated with connective tissue disease, autoimmune antibody tests may also be necessary. Many biomarkers associated with disease prognosis have been recently discovered, and future research on their clinical significance is necessary. The diagnosis of ILD is difficult because patterns of ILD are both complicated and variable. Therefore, as with other diseases, accurate history taking and meticulous physical examination are crucial.

Keyword

Lung Diseases, Interstitial; Idiopathic Interstitial Pneumonias; Classification; Diagnosis

MeSH Terms

Biomarkers
Biopsy
Classification
Connective Tissue Diseases
Cryptogenic Organizing Pneumonia
Diagnosis*
Idiopathic Interstitial Pneumonias
Idiopathic Pulmonary Fibrosis
Lung
Lung Diseases
Lung Diseases, Interstitial*
Physical Examination
Prognosis
Respiratory Function Tests
Thorax
Biomarkers
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error